Using real-world data, a team of U.S.-based investigators analyzed survival outcomes among an independent cohort of patients with metastatic urothelial cancer (UC) treated with immune checkpoint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback